PDH is engaged in developing and operating diagnostic imaging clinics in Canada and China, with a focus on PET-CT Scanning (positron emission tomography – computed tomography).
Partnering with GeneDiagnostic in the PDH Marketing Development Program is part of the PDH strategy designed to quickly identify and realize on opportunities and accelerate completion of joint venture agreements for the establishment and operation of Premier Diagnostic Centres in hospitals.
PDH CEO Denis Tusar said the agreement with GeneDiagnostic rounds out their China market development team, together with International Sales director Leonhard Braunizer and Market Development manager Kathy Su.
